2023年6月至11月香港9月龄至17岁儿童流感疫苗对甲型H3N2流感相关住院的疫苗效果
2023年6月13日至11月15日在香港开展检测阴性研究,纳入3183例因急性呼吸道疾病住院的儿童,其中528例(16.6%)检出流感病毒,419例(79.4%)为甲型H3N2。流感疫苗对任何流感病毒相关住院的总体疫苗效果为22.4%(95%CI:-11.7%,46.1%),对甲型H3N2相关住院的疫苗效果为14.3%(95%CI:-29.2%,43.2%)。尽管疫苗效果为中低水平,接种流感疫苗仍是减少儿童流感影响的重要方法。
要点
- 检测阴性研究纳入3183例住院儿童,528例(16.6%)检出流感病毒。
- 甲型H3N2占检出流感病毒的79.4%(419/528)。
- 对任何流感病毒相关住院的疫苗效果为22.4%(95%CI:-11.7%,46.1%)。
核心结论
- 尽管估计的疫苗效果为中低水平,可能因免疫衰减和抗原漂移所致,接种流感疫苗仍是减少儿童流感影响的重要方法。
研究设计与样本
- 检测阴性研究于2023年6月13日至11月15日在香港开展,纳入3183例因急性呼吸道疾病住院的儿童。
主要发现
- 528例(16.6%)儿童检出甲型和乙型流感病毒,其中419例(79.4%)为甲型H3N2。
- 针对任何流感病毒相关住院的总体疫苗效果为22.4%(95%CI:-11.7%,46.1%)。
- 针对甲型H3N2相关住院的疫苗效果为14.3%(95%CI:-29.2%,43.2%)。
局限性
- 原文指出估计的疫苗效果为中低水平,可能因免疫衰减和抗原漂移所致。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A test negative study was carried out from 13 June through to 15 November 2023 enrolling 3183 children hospitalized with acute respiratory illness in Hong Kong. Influenza A and B viruses were detected in 528 (16.6%) children, among which 419 (79.4%) were influenza A(H3N2). The overall vaccine effectiveness against hospitalization associated with any influenza virus infection was estimated as 22.4% (95% CI: -11.7%, 46.1%), and against influenza A(H3N2) specifically was 14.3% (95% CI: -29.2%, 43.2%). Despite the moderate to low VE estimated here, which could be a result of waning immunity and antigenic drift, influenza vaccination remains an important approach to reduce the impact of influenza in children.
引用
- Murphy C, Kwan MYW, Chan ELY, et al. Influenza vaccine effectiveness against hospitalizations associated with influenza A(H3N2) in Hong Kong children aged 9 months to 17 years, June-November 2023. Vaccine. 2024. PMID: 38395722. doi:10.1016/j.vaccine.2024.02.056
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。